Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Stonehenge Growth Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 6
Rounds per year 0.29
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 3
Key employees 4

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Medical
  • Life Science
Summary

Stonehenge Growth Capital is the famous VC, which was founded in 1999. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Dallas.

The increased amount of exits for fund were in 2017. The typical startup value when the investment from Stonehenge Growth Capital is 5-10 millions dollars. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2017. Opposing the other organizations, this Stonehenge Growth Capital works on 31 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations.

The standard case for the fund is to invest in rounds with 2 partakers. Despite the Stonehenge Growth Capital, startups are often financed by Stonehenge Capital, McKnight Foundation, Connecticut Innovations. The meaningful sponsors for the fund in investment in the same round are Connecticut Innovations, Trillium Group, Benslie International Ltd. In the next rounds fund is usually obtained by Stonehenge Capital, Norwest Venture Partners, HighCape Partners.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight PosiGen, iCardiac Technologies, PCC Technology Group. The fund has no exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Stonehenge Growth Capital:
Typical Co-investors
Stonehenge Growth Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Stonehenge Growth Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Cub Capital -
EastOne Group -
Everbright-IDG Industrial Fund Beijing, Beijing, China
Fujian Innovation Investment Management -
Jinzhuo Hengbang Technology China, Jinzhou, Liaoning
Mizuho Securities Chiyoda, Japan
Nanping Baiyi China, Fujiang, Sichuan
NetScientific England, London, United Kingdom
SmartSens Technology China, Shanghai
Total Ventures France, Ile-de-France, La Défense

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

iCardiac Technologies

Biopharma
Biotechnology
Health Care
Life Science
14 Nov 2007 Rochester, New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Stonehenge Growth Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 2M
Rounds per year 0.29
Peak activity year 2017
Lead investments 3
Follow on index 0.14
Exits 3
Group Appearance index 0.57

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

iCardiac Technologies

Biopharma
Biotechnology
Health Care
Life Science
14 Nov 2007 Rochester, New York, United States
Crunchbase icon

Content report

The following text will be sent to our editors: